Farallon Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,409,718
Closed -$188M 161
2024
Q2
$188M Buy
2,409,718
+950,000
+65% +$74.1M 0.81% 35
2024
Q1
$98.9M Sell
1,459,718
-2,364,573
-62% -$160M 0.42% 42
2023
Q4
$258M Sell
3,824,291
-2,235,262
-37% -$151M 1.18% 27
2023
Q3
$410M Hold
6,059,553
1.92% 15
2023
Q2
$434M Buy
6,059,553
+192,000
+3% +$13.7M 2.18% 11
2023
Q1
$407M Sell
5,867,553
-8,909
-0.2% -$618K 2.22% 11
2022
Q4
$398M Buy
5,876,462
+291,500
+5% +$19.8M 2.35% 9
2022
Q3
$306M Buy
5,584,962
+955,000
+21% +$52.4M 1.68% 14
2022
Q2
$306M Buy
4,629,962
+1,053,778
+29% +$69.6M 1.66% 16
2022
Q1
$237M Buy
3,576,184
+1,670,029
+88% +$111M 1.15% 31
2021
Q4
$111M Buy
1,906,155
+1,572,155
+471% +$91.6M 0.55% 44
2021
Q3
$20.1M Buy
+334,000
New +$20.1M 0.09% 98
2019
Q4
Sell
-2,375,785
Closed -$106M 114
2019
Q3
$106M Sell
2,375,785
-1,724,215
-42% -$76.8M 0.8% 30
2019
Q2
$169M Buy
4,100,000
+215,000
+6% +$8.88M 1.1% 24
2019
Q1
$157M Hold
3,885,000
1.18% 25
2018
Q4
$148M Buy
3,885,000
+465,000
+14% +$17.7M 1.08% 26
2018
Q3
$135M Sell
3,420,000
-430,000
-11% -$17M 0.8% 30
2018
Q2
$135M Buy
3,850,000
+285,000
+8% +$10M 0.83% 29
2018
Q1
$125M Sell
3,565,000
-200,000
-5% -$6.99M 0.86% 31
2017
Q4
$131M Buy
3,765,000
+585,000
+18% +$20.3M 1.06% 27
2017
Q3
$108M Buy
3,180,000
+2,605,000
+453% +$88.3M 0.96% 27
2017
Q2
$19.6M Sell
575,000
-577,500
-50% -$19.7M 0.2% 54
2017
Q1
$35.9M Buy
1,152,500
+787,500
+216% +$24.5M 0.39% 41
2016
Q4
$9.97M Buy
+365,000
New +$9.97M 0.11% 53